A Randomized, Vehicle-Controlled Study of 2 Concentrations of A-101 for the Treatment of Seborrheic Keratosis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Stuart D Shanler, MD
Aclaris Therapeutics, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Center for Dermatology and Dermatologic Surgery
Washington D.C., District of Columbia, United States
- Baumann Research Institute
Miami, Florida, United States
- Medaphase, Inc
Newnan, Georgia, United States
- Union Square Laser Dermatology
New York, New York, United States
- Philadelphia Institute - Dermatology
Fort Washington, Pennsylvania, United States
- Perelman Center for Advanced Medicine
Philadelphia, Pennsylvania, United States
- Greenville Dermatology
Greenville, South Carolina, United States
- the Skin Wellness Center, Pc Clinical Research Division
Knoxville, Tennessee, United States
- Dermresearch Inc
Austin, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 17 May 2017
- Primary completion
- 28 Feb 2018
- Completion
- 3 Apr 2018
- Last update posted
- 6 May 2019
- Registered enrollment
- 253
- Registry id
- NCT03148691
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.